Legal full-text edition
Emerging Therapies for Malignant Mesothelioma
malignant mesotheliomatumor biologypreclinical modelsimmune environmentangiogenesis inhibitorschemotherapyimmunotherapy
Rights
Public-domain status shown for GLOBAL. DOAB open-access record with explicit license: CC-BY
Public-domain status shown for GLOBAL. DOAB open-access record with explicit license: CC-BY